获得治疗隐球菌脑膜炎患者的药物

Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America Pub Date : 2022-08-29 DOI:10.1093/cid/ciac689/6678599

J. Burry, C. P. Casas, N. Ford

{"title":"获得治疗隐球菌脑膜炎患者的药物","authors":"J. Burry, C. P. Casas, N. Ford","doi":"10.1093/cid/ciac689/6678599","DOIUrl":null,"url":null,"abstract":"Cryptococcal meningitis accounts for one in five AIDS-related deaths globally. WHO guidelines strongly recommend a single high-dose of liposomal amphotericin B as part of preferred treatment, but this drug remains unaffordable in most low- and middle-income countries. A proactive approach is needed from manufacturers and other stakeholders to improve access.","PeriodicalId":10421,"journal":{"name":"Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America","volume":"16 1","pages":"e773 - e775"},"PeriodicalIF":0.0000,"publicationDate":"2022-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":"{\"title\":\"Access to medicines for treating people with cryptococcal meningitis\",\"authors\":\"J. Burry, C. P. Casas, N. Ford\",\"doi\":\"10.1093/cid/ciac689/6678599\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Cryptococcal meningitis accounts for one in five AIDS-related deaths globally. WHO guidelines strongly recommend a single high-dose of liposomal amphotericin B as part of preferred treatment, but this drug remains unaffordable in most low- and middle-income countries. A proactive approach is needed from manufacturers and other stakeholders to improve access.\",\"PeriodicalId\":10421,\"journal\":{\"name\":\"Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America\",\"volume\":\"16 1\",\"pages\":\"e773 - e775\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-08-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"5\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/cid/ciac689/6678599\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/cid/ciac689/6678599","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 5

摘要

隐球菌脑膜炎占全球艾滋病相关死亡人数的五分之一。世卫组织指南强烈建议将单次高剂量两性霉素B脂质体作为首选治疗的一部分，但这种药物在大多数低收入和中等收入国家仍然负担不起。制造商和其他利益攸关方需要采取积极主动的方法来改善获取。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Access to medicines for treating people with cryptococcal meningitis

Cryptococcal meningitis accounts for one in five AIDS-related deaths globally. WHO guidelines strongly recommend a single high-dose of liposomal amphotericin B as part of preferred treatment, but this drug remains unaffordable in most low- and middle-income countries. A proactive approach is needed from manufacturers and other stakeholders to improve access.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America

自引率

0.00%

发文量